Tumor Markers: A Guide to Laboratory Testing
Tumor markers are substances found in blood, urine, or tissue that can be measured by laboratory tests. They are sometimes produced by cancer cells or by the body in response to cancer. This guide explains how tumor markers are used, what results can and cannot show, and why they are rarely used alone to diagnose cancer.
Key takeaways
- Tumor markers are laboratory measurements, not a diagnosis by themselves.
- They are most often used to monitor known cancer, assess response to treatment, or watch for recurrence.
- A normal tumor marker level does not rule out cancer, and an elevated level does not prove cancer.
- Some tumor markers are used for screening in specific high-risk groups, but only alongside other tests.
- Results must always be interpreted with a person's history, imaging, and other clinical findings.
What Are Tumor Markers?
Tumor markers are biological substances that can be detected in blood, urine, body fluids, or tissue samples. They may be proteins, hormones, enzymes, or other molecules produced by cancer cells or by normal cells in response to cancer. Some markers are specific to one type of cancer, while others can rise in several conditions, including benign diseases.
Laboratory testing for tumor markers usually involves a blood draw, though some markers are measured in urine or on tissue samples removed during a biopsy. The test measures the amount of the marker present, and results are compared with a reference range established by the performing laboratory. Because different laboratories may use different methods and reference ranges, results are best interpreted over time by the same laboratory whenever possible.
How Tumor Markers Are Used in Clinical Care
Tumor markers are most commonly used after a cancer diagnosis has been established by other means, such as imaging or biopsy. In this setting, a marker that is elevated before treatment can be tracked over time. A falling level may suggest the cancer is responding to treatment, while a rising level may prompt further evaluation. This monitoring role is one of the best-established uses of tumor markers.
In some situations, tumor markers are used to help estimate prognosis, guide treatment decisions, or detect recurrence after treatment ends. For a small number of cancers, markers are part of screening programs for people at high risk. For example, certain markers may be checked in individuals with a strong family history or known genetic risk, but screening decisions are made with a clinician who considers the balance of benefits and harms.
Limitations and False Results
Tumor markers are not stand-alone diagnostic tests. Many non-cancerous conditions can raise marker levels, including inflammation, infection, liver disease, kidney disease, and benign tumors. Conversely, some cancers do not produce measurable markers, so a normal result does not exclude cancer. This is why a tumor marker result is always interpreted alongside a person's symptoms, physical examination, imaging studies, and biopsy findings.
False-positive and false-negative results are possible with any laboratory test. A false-positive result may lead to unnecessary anxiety and additional procedures, while a false-negative result may provide false reassurance. Because of these limitations, most medical organizations do not recommend tumor markers as general screening tests for people at average risk. Their value depends on the specific marker, the cancer type, and the clinical context.
Common Tumor Markers and What They Measure
Several tumor markers are widely used in oncology. Examples include CA-125, which can be elevated in ovarian cancer and other conditions; CEA, often used in colorectal cancer monitoring; AFP, associated with liver and germ cell tumors; PSA, used in prostate cancer evaluation and monitoring; and CA 19-9, used mainly in pancreatic cancer monitoring. Each marker has its own pattern of behavior and its own set of non-cancer causes of elevation.
Some markers are measured on tissue rather than in blood. For instance, hormone receptors and certain proteins in breast cancer tissue help guide treatment choices. These tissue-based markers are different from circulating blood markers, but they serve a similar purpose: providing information that helps clinicians understand a cancer and plan care. A pathologist typically evaluates tissue markers, while a clinical laboratory measures blood or urine markers.
What to Expect From Testing
If a clinician orders a tumor marker test, a blood sample is usually collected in a clinic or laboratory. Results are reported as a numeric value with a reference range. Because marker levels can fluctuate, a single result is often less meaningful than a series of results collected over time. Your clinician will consider the trend, not just one number, when making decisions.
Before testing, it is reasonable to ask why the test is being ordered, how the result will be used, and whether it will change your care. If you are monitoring a known cancer, ask how often testing will occur and what changes would prompt further evaluation. Keep a record of your results so you can discuss trends with your care team. Tumor markers are one tool among many, and they are most useful when placed in the full context of your health.
Frequently Asked Questions
Can a tumor marker test diagnose cancer?
No. Tumor markers alone cannot diagnose cancer. An elevated level may suggest the need for further testing, but a diagnosis generally requires imaging, biopsy, and examination by a pathologist. Some non-cancerous conditions can also raise marker levels.
What does it mean if my tumor marker level is normal?
A normal result does not rule out cancer. Some cancers do not produce measurable markers, and marker levels can be normal even when cancer is present. Your clinician will interpret the result with other findings.
Why do tumor marker results vary between laboratories?
Laboratories may use different testing methods, equipment, and reference ranges. For this reason, tracking results over time is usually more reliable when the same laboratory and method are used consistently.
Are tumor markers used for screening in healthy people?
In general, no. Most medical organizations do not recommend tumor markers for routine screening in people at average risk because of concerns about false-positive and false-negative results. In selected high-risk groups, a clinician may include a marker as part of a broader screening plan.
Sources
Ready to get tested? Examine the included markers, read the collection notes, and reserve the panel with the TestRequisition partner today.
Order Alpha-Fetoprotein (AFP) Tumor Marker TestReviewed by the TestRequisition Editorial Team
The TestRequisition editorial team reviews laboratory panels against published reference material before publication.